C
TransMedics Group, Inc. TMDX
$89.36 $0.951.08% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2026 03/31/2026 12/31/2025 09/30/2025 06/30/2025
Net Income 151.70M 171.92M 190.29M 91.77M 71.66M
Total Depreciation and Amortization 33.62M 30.51M 25.49M 24.20M 23.33M
Total Amortization of Deferred Charges 2.80M 2.40M 1.70M 1.20M 400.00K
Total Other Non-Cash Items -27.99M -36.03M -43.01M 42.94M 41.18M
Change in Net Operating Assets -14.21M 51.42M 18.38M 17.88M -21.30M
Cash from Operations 145.93M 220.23M 192.84M 177.99M 115.27M
Capital Expenditure -66.89M -68.87M -59.25M -57.34M -97.92M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- 0.00 441.00K
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -66.89M -68.87M -59.25M -57.34M -97.48M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 11.79M 17.87M 17.00M 15.08M 19.17M
Repurchase of Common Stock -315.00K -276.00K -138.00K -138.00K --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 11.47M 17.59M 16.86M 14.94M 19.17M
Foreign Exchange rate Adjustments -475.00K 585.00K 1.27M 489.00K 866.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 90.04M 169.53M 151.72M 136.08M 37.82M